BridgeMD
Oral antibiotics to prevent infection and wound dehiscence after obstetric perineal tear
EU CTIS ID: 2022-501930-49-00
What this study is testing
To investigate wheather three doses of oral antibiotics given to women with an obstetric perineal wound can reduce the risk of infection and wound dehiscence compared to placebo treatment
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Women with a second degree tear or an episiotomy of the perineum after a vaginal delivery
- Women above 18 year
- Women wh speaks and read Danish
- Women who are mentally capable of giving informed consent at time of inclusion
- Tear being sutured at Herlev Hospital
You likely can't join if
- Women with allergies towards the used drug
- Women who ends in Caesarean section even though she has a vaginal tear og episiotomy
- Women that for any other reasons recieve antbiotics during or after labour
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.